Valuation: Ibnsina Pharma

Market Cap 11.56B 226M 198M 183M 168M 319M 21.84B 324M 2.19B 859M 10.68B 850M 832M 36.8B P/E 2026 *
9.42x
P/E 2027 * 6.44x
Enterprise Value 17.38B 340M 298M 276M 253M 479M 32.83B 487M 3.29B 1.29B 16.05B 1.28B 1.25B 55.32B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.17x
Free-Float
70.08%
Yield 2026 *
2.62%
Yield 2027 * 5.06%
1 day-0.09%
1 week-0.26%
Current month-1.71%
1 month-5.91%
3 months+6.60%
6 months+6.70%
Current year-2.13%
1 week 11.2
Extreme 11.2
11.65
1 month 11.2
Extreme 11.2
12.71
Current year 9.63
Extreme 9.63
13.72
1 year 9.63
Extreme 9.63
13.72
3 years 1.78
Extreme 1.78
13.72
5 years 1.1
Extreme 1.101
13.72
10 years 1.1
Extreme 1.101
13.72
Manager TitleAgeSince
Chief Executive Officer - 2000-12-17
Chief Executive Officer - 2000-12-17
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 2000-12-17
Director/Board Member - 2000-12-17
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%-0.26%+18.61%+398.70% 229M
+2.85%+2.63%-19.75%-26.17% 15.14B
+2.68%-0.58%-26.60%-30.44% 6.93B
+2.53%+4.48%-20.28%-5.91% 6.13B
+3.36%+7.06%-9.08%-28.23% 3.73B
+2.36%+1.93%-38.19%-11.11% 3.25B
-0.39%-2.17%-31.14%-49.78% 3.13B
+1.35%+6.63%+10.77%-29.70% 3.12B
-1.83%-2.88%+96.15% - 2.57B
+0.64%+4.08%-17.85%+2.41% 2.53B
Average +1.35%+0.35%-3.73%+24.42% 4.68B
Weighted average by Cap. +2.08%+0.16%-13.34%-21.18%

Financials

2026 *2027 *
Net sales 89.87B 1.76B 1.54B 1.43B 1.31B 2.48B 170B 2.52B 17.03B 6.67B 82.98B 6.61B 6.47B 286B 101B 1.98B 1.73B 1.61B 1.47B 2.79B 191B 2.83B 19.18B 7.51B 93.43B 7.44B 7.28B 322B
Net income 1.33B 25.99M 22.74M 21.05M 19.33M 36.58M 2.51B 37.15M 251M 98.51M 1.22B 97.58M 95.44M 4.22B 1.92B 37.7M 33M 30.54M 28.04M 53.07M 3.64B 53.9M 365M 143M 1.78B 142M 138M 6.13B
Net Debt 5.82B 114M 99.73M 92.32M 84.75M 160M 10.99B 163M 1.1B 432M 5.37B 428M 418M 18.52B 5.77B 113M 98.96M 91.6M 84.09M 159M 10.9B 162M 1.09B 429M 5.33B 425M 415M 18.37B
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
26-07-20 EGP 11.47 -0.09% 3,122,576
26-07-19 EGP 11.48 -0.17% 5,321,851
26-07-16 EGP 11.50 +1.05% 7,067,204
26-07-15 EGP 11.38 -0.18% 4,143,450
26-07-14 EGP 11.40 -0.61% 4,162,006
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
11.47EGP
Average target price
17.26EGP
Spread / Average Target
+50.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISPH Stock